163217-70-7,
4-Hydroxy Atorvastatin Lactone,
P-HYDROXYATORVASTATIN LACTONE,
p-Hydroxy atorvastatin lactone,
UNII-1316I46GEX,
1316I46GEX,
5-(4-Fluorophenyl)-1-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)-ethyl)-N-(4-hydroxyphenyl)-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxamide,
(2R-Trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N-(4-hydroxyphenyl)-4-phenyl-1-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl)-1H-pyrrole-3-carboxamide,
1H-Pyrrole-3-carboxamide, 5-(4-fluorophenyl)-N-(4-hydroxyphenyl)-2-(1-methylethyl)-4-phenyl-1-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-,
5-(4-fluorophenyl)-1-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-N-(4-hydroxyphenyl)-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxamide,
5-(4-Fluorophenyl)-N-(4-hydroxyphenyl)-2-(1-methylethyl)-4-phenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide,
(2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N-(4-hydroxyphenyl)-4-phenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1H-pyrrole-3-carboxamide,
1H-Pyrrole-3-carboxamide, 5-(4-fluorophenyl)-N-(4-hydroxyphenyl)-2-(1-methylethyl)-4-phenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-,
SCHEMBL5605468,
CTK8E9693,
DTXSID90167535,
para-Hydroxy Atorvastatin Lactone,
KDJMDZSAAFACAM-KAYWLYCHSA-N,
ZINC3932198,
para-Hydroxy Atorvastatin-d5 Lactone,
AKOS015914523,
1H-Pyrrole-3-carboxamide, 5-(4-fluorophenyl)-N-(4-hydroxyphenyl)-2-(1-methylethyl)-4-phenyl-1-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-, (2R-trans)-,
RT-009693,
FT-0669406,
FT-0669407,
C-35646,
J-010020,
I14-41526,
265989-49-9,
5-(4-Fluorophenyl)-N-(4-Hydroxyphenyl)-2-(1-Methylethyl)-4-Phenyl-1-[2-[(2R,4R)-Tetrahydro-4-Hydroxy,
CID9937602,
CS-O-07274,
CID 9937602,